Syra HealthSYRA -3.81%12 OCF Margin % is 59.89% as of Mar. 2026. GuruFocus rates SYRA with a GF Score™ of 12/100 and a GF Value™ of $0.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Syra Health ranks better than 53.92% on this metric.
The historical rank and industry rank for Syra Health's OCF Margin % or its related term are showing as below:
SYRA'
s OCF Margin % Range Over the Past 10 Years
Min: -50.03 Med: -36.73 Max: -6.2
Current: 9.91
During the past 6 years, the highest OCF Margin % of Syra Health was -6.20%. The lowest was -50.03%. And the median was -36.73%.
SYRA's OCF Margin % is ranked better than 53.92% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 8.255
vs SYRA: 9.91
Syra Health OCF Margin % Related Terms
Syra Health OCF Margin % Historical Data
* Premium members only.
The historical data trend for Syra Health's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Syra Health's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syra Health OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Syra Health's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syra Health (SYRA) has a OCF Margin % of 59.89% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Syra Health and its competitors. According to the industry distribution chart, Syra Health ranks #306 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 46.1%.
Is Syra Health's OCF Margin % too high?
Syra Health's current OCF Margin % is 59.89%. The Healthcare Providers & Services industry median OCF Margin % is 8.26. Syra Health's value of 59.89% is 625.5% above this industry median. Based on the distribution chart, Syra Health ranks #306 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Syra Health has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's OCF Margin % compare to NIVF and BICX?
According to the Healthcare Providers & Services industry distribution chart, Syra Health ranks #306 out of 664 companies for OCF Margin %. This puts Syra Health in the upper half of its industry. The industry median OCF Margin % is 8.26. Syra Health's value of 59.89% is 625.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.26, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syra Health's current OCF Margin % of 59.89% is 625.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Syra Health and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syra Health's current OCF Margin % is 59.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.70 — trading 205.2% above its estimated fair value. The current OCF Margin % is 59.89% and 625.5% above the Healthcare Providers & Services industry median of 8.26. Syra Health's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Syra Health (SYRA), the current OCF Margin % is 59.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syra Health (SYRA) Overvalued in 2026?
Based on GuruFocus' analysis, Syra Health stock appears to be overvalued.
The current stock price of $0.70 is trading 205.2% above its estimated GF Value™ of $0.23.
GuruFocus considers Syra Health to be Significantly Overvalued.
Key valuation signals for SYRA:
OCF Margin %: 59.89%
GF Value™: $0.23 vs. price of $0.70 (205.2% above fair value)
Industry Position: 625.5% above the Healthcare Providers & Services median (#306 of 664)
No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score
Get the complete analysis for SYRA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYRA has been successfully added to your 
